Endoscopic Manifestations and Clinical Characteristics of Localized Gastric Light-Chain Amyloidosis

To determine the endoscopic and clinical features of localized gastric amyloid light-chain (AL) amyloidosis, we retrospectively examined the characteristics of nine patients (eight men and one woman) encountered by the hospitals in our network. Lesions were predominantly flat and depressed with surface vascular dilatation (n = 5); others were characterized by subepithelial lesions (n = 2), mucosal color change (n = 1), and a mass-like morphology with swollen mucosal folds (n =1). Colonoscopy (n = 7), video capsule enteroscopy (n = 2), serum (n =5) and urine immunoelectrophoresis (n = 4), and bone marrow examination (n =3) were performed to exclude involvement of organs other than the stomach. As treatment for gastric lesions of AL amyloidosis, one patient each underwent endoscopic submucosal dissection (n =1) and argon plasma coagulation (n = 1), while the remaining seven patients underwent no specific treatment. During a mean follow-up of 4.2 years, one patient died 3.2 years after diagnosis, but the cause of death, which occurred in another hospital, was unknown. The remaining eight patients were alive at the last visit. In conclusion, although localized gastric AL amyloidosis can show various macroscopic features on esophagogastroduodenoscopy, flat, depressed lesions with vascular dilatation on the surface are predominant.